Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Feasibility and Effectiveness of tDCS in the Treatment of Post-stroke Fatigue (EFECTS).

NCT: NCT06149897 · COMPLETED

NCT IDNCT06149897
StatusCOMPLETED
Start Date2023-11-10
Completion2026-05-21

Brief Summary

This study aims to analyze the use of non-invasive brain stimulation (tDCS) is beneficial for the treatment of post-stroke fatigue.

Frequently Asked Questions

What is Feasibility and Effectiveness of tDCS in the Treatment of Post-stroke Fatigue (EFECTS).?

Feasibility and Effectiveness of tDCS in the Treatment of Post-stroke Fatigue (EFECTS). is a clinical trial registered under NCT06149897. Current status: COMPLETED.

What is the status of NCT06149897?

The current status of NCT06149897 (Feasibility and Effectiveness of tDCS in the Treatment of Post-stroke Fatigue (EFECTS).) is: COMPLETED.

When did Feasibility and Effectiveness of tDCS in the Treatment of Post-stroke Fatigue (EFECTS). start?

Feasibility and Effectiveness of tDCS in the Treatment of Post-stroke Fatigue (EFECTS). started on 2023-11-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑